Advertisement

Journal of Neuro-Oncology

, Volume 102, Issue 3, pp 425–425 | Cite as

Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma

  • Raffaele AddeoEmail author
  • Michele Caraglia
  • M. Serena De Santi
  • Liliana Montella
  • Alberto Abbruzzese
  • Ciro Parlato
  • Bruno Vincenzi
  • Marco Carraturo
  • Vincenzo Faiola
  • Michele Genovese
  • Gregorio Cennamo
  • Salvatore Del Prete
Open Access
Erratum

Erratum to: J Neurooncol DOI 10.1007/s11060-010-0329-z

The Abstract section of the original publication contains the following two errors:
  • right column, lines 6–7: “...then every 3 weeks at 100 mg/m2...” should read “...then every 4 weeks at 80 mg/m2...”.

  • right column, lines 16–17: “Progression-free survival at 6 months was 61%.” should read “Progression-free survival at 6 months was 39%.”.

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Raffaele Addeo
    • 1
    Email author
  • Michele Caraglia
    • 2
  • M. Serena De Santi
    • 3
  • Liliana Montella
    • 1
  • Alberto Abbruzzese
    • 2
  • Ciro Parlato
    • 4
  • Bruno Vincenzi
    • 5
  • Marco Carraturo
    • 6
  • Vincenzo Faiola
    • 7
  • Michele Genovese
    • 3
  • Gregorio Cennamo
    • 1
  • Salvatore Del Prete
    • 1
  1. 1.Oncology Department‘‘S. Giovanni di Dio’’ HospitalFrattaminoreItaly
  2. 2.Department of Biochemistry and BiophysicsSecond University of NaplesNaplesItaly
  3. 3.Neurosurgery Department‘‘Umberto I’’ Hospital ASL SANocera InferioreItaly
  4. 4.Department of NeurosurgerySecond University of NaplesNaplesItaly
  5. 5.Section of OncologyCampus Biomedico UniversityRomeItaly
  6. 6.Radiotherapy UnitASL Napoli 2 NordAcerraItaly
  7. 7.Oncology UnitAORN ‘‘Ruggi D’Aragona’’ HospitalSalernoItaly

Personalised recommendations